NFE2L2 and colitis: Our current findings firstly suggested that PF-04447943 attenuates the DSS-induced colitis by suppressing oxidative stress, inflammation, inflammasome and the Treg/Th17 cells balance, and the mechanisms involved in regulating NF-kB, STAT3, Nrf2, and MAPK (ERK) pathway.